We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 252.50
Bid: 250.50
Ask: 252.00
Change: -4.50 (-1.75%)
Spread: 1.50 (0.599%)
Open: 257.00
High: 257.00
Low: 251.00
Prev. Close: 257.00
CMCX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ESMA Announcement

27 Mar 2018 10:30

RNS Number : 0685J
CMC Markets Plc
27 March 2018
 

27 March 2018

 

 

CMC Markets Plc

 

ESMA Announcement

 

 

CMC Markets Plc ("CMC") notes the announcement by the European Securities and Markets Authority (ESMA) issued today.

ESMA's announcement introduces temporary product intervention measures on the provision of contracts for difference (CFDs) and binary options to retail investors. The measures announced today are largely unchanged from those proposed by ESMA in December 2017. The FCA expects to consult on whether to apply these measures on a permanent basis. The measures introduced include the following:-

1. A prohibition on the marketing, distribution or sale of binary options to retail clients; and

2. Restrictions on the marketing, distribution or sale to retail clients of CFDs, including rolling spot forex and financial spread bets as follows:

 

- leverage limits on the opening of a CFD position by a retail client between 30:1 and 2:1, depending on the volatility of the underlying asset;

- a standard margin close-out rule on a per-account basis;

- negative balance protection on a per account basis;

- a prohibition on firms offering monetary and non-monetary benefits to retail investors; and

- a standardised risk warning, including firm-specific figures on the percentage of clients that have lost money trading CFDs.

 

CMC is well prepared for these measures and through its proprietary technology, will ensure that they are implemented as required. Fair client outcomes have always been a focus of the Group, with account level margin close-out and standard risk warnings already in place throughout the Group, as well as negative balance protection being offered in certain countries.

Binary products generated £2.1m of revenues from the UK and Europe in H1 18 and therefore any reduction in revenue will be immaterial in a Group context.

Margin changes are likely to have an impact on how clients trade, although at this stage it is not possible to quantify the impact. However, CMC remains confident that its strategy of targeting high value, experienced clients that could be categorised as 'elective professionals', puts it in a strong position to manage regulatory change.

 

Enquiries

CMC Markets Plc +44 (0) 20 7170 8200

Grant Foley, Chief Operating and Financial Officer

 

Camarco +44 (0) 20 3757 4984

Geoffrey Pelham-Lane

Ed Gascoigne-Pees

Jennifer Renwick

 

 

 

 

 

 

Notes to Editors

CMC Markets plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The company serves retail and institutional clients through regulated offices and branches in 14 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKODBCBKKFNB
Date   Source Headline
8th Apr 20243:12 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSFY 2024 Pre-Close Trading Update
6th Mar 20242:37 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:03 amRNSNotification Under Listing Rule 9.6.14
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSCost reduction and efficiency plans
30th Jan 20249:37 amRNSDirector/PDMR Shareholding
16th Jan 20244:57 pmRNSDirector/PDMR Shareholding
8th Jan 202410:43 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSTrading Statement
6th Dec 20239:54 amRNSDirector/PDMR Shareholding
1st Dec 202312:54 pmRNSDirector/PDMR Shareholding
1st Dec 202312:49 pmRNSDirector/PDMR Shareholding
1st Dec 202312:41 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
7th Nov 20231:58 pmRNSDirector/PDMR Shareholding
6th Oct 20233:27 pmRNSDirector/PDMR Shareholding
25th Sep 202311:11 amRNSDirector/PDMR Shareholding
18th Sep 20232:48 pmRNSHolding(s) in Company
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
25th Aug 20237:00 amRNSTrading Statement
16th Aug 20231:52 pmRNSDirector/PDMR Shareholding
9th Aug 202312:13 pmRNSDirector/PDMR Shareholding
9th Aug 202312:11 pmRNSDirector/PDMR Shareholding
9th Aug 202312:10 pmRNSDirector/PDMR Shareholding
8th Aug 202310:00 amRNSDirector/PDMR Shareholding
27th Jul 20233:27 pmRNSResult of AGM
27th Jul 20237:00 amRNSTrading Statement
21st Jul 202311:20 amRNSDirector/PDMR Shareholding
21st Jul 202310:07 amRNSDirector/PDMR Shareholding
12th Jul 202310:27 amRNSDirector/PDMR Shareholding
7th Jul 202310:09 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSDirectorate Change
23rd Jun 20235:09 pmRNSNotice of AGM
13th Jun 20237:00 amRNSFinal Results
9th Jun 20237:00 amRNSInvestment in StrikeX Technologies
6th Jun 20231:48 pmRNSDirector/PDMR Shareholding
9th May 20231:34 pmRNSDirector/PDMR Shareholding
6th Apr 20233:40 pmRNSDirector/PDMR Shareholding
31st Mar 202310:56 amRNSHolding(s) in Company
27th Mar 20233:51 pmRNSTrading Statement
7th Mar 20232:49 pmRNSDirector/PDMR Shareholding
7th Feb 202311:37 amRNSDirector/PDMR Shareholding
25th Jan 20237:00 amRNSTrading Statement
9th Jan 20232:15 pmRNSDirector/PDMR Shareholding
9th Jan 202312:50 pmRNSDirector/PDMR Shareholding
6th Jan 20233:22 pmRNSDirector/PDMR Shareholding
14th Dec 202212:38 pmRNSDirectorate Change
6th Dec 20222:38 pmRNSDirector/PDMR Shareholding
21st Nov 20221:54 pmEQSCMC Markets 'to continue rolling out investment platform'

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.